Results showing the effectiveness of the vaccine in dogs were recently published in the journal Vaccine

Integra Holdings closes U.S. $ 7.0 million private financing

Novel biocontrol agent is environmentally-friendly, non-toxic and effective for a large variety of plants

The novel method uses a peptide derived from HIV to increase the sensitivity of cancer cells to radiotherapy and chemotherapy

Yaacov Michlin appointed Chairman of the Board and Dr. Yona Geffen appointed Chief Executive Officer

Technology, to be presented at Agritech Israel 2012, enables better control over fish reproduction cycle, increasing spawning and fish size 

Yissum, the research and development company of the Hebrew University of Jerusalem, North Carolina State University, Raleigh , N.C., and Dow AgroFresh, a business unit of Rohm and Haas Company, a wholly owned subsidiary of The Dow Chemical Company, signed a license agreement for the development and commercialization of a novel water-soluble ethylene-antagonist for agricultural applications.

Atox Bio will be included as one of the portfolio companies of Integra Holdings, a holding company currently formed by Yissum, the technology transfer company of the Hebrew University of Jerusalem.

The work was published in the latest issue of the prestigious Nature Biotechnology journal 

Technology to be presented at WATEC, the Water Technologies, Renewable Energy and Environmental Control Exhibition and Conference 

Yissum will now maintain 30% holding share in Avraham Pharmaceuticals, which will be transferred to its forthcoming biotech holdings company 

The novel technology has been proven effective in a number of plant species

The first research funded focuses on forecasting of car sales

BL-7040 has dual activity on both the nervous and immune systems, rendering it highly suitable for treating both neurological diseases and immune system related conditions such as inflammatory or autoimmune diseases. It was invented by HUJI Professor Hermona Soreq.

The device was presented for the 1st time at the Israeli Presidential Conference, which is held in collaboration with the Hebrew University of Jerusalem

Prof. Haim Rabinowitch, Prof. Dan Gazit and Dr. Raanan Fattal were all awarded the prestigious Kaye Award which is dedicated to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society.

Prof. Haim Rabinowitch, Prof. Dan Gazit and Dr. Raanan Fattal were all awarded the prestigious Kaye Award which is dedicated to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society. 

The technology, invented by Professor Simon Benita, Head of Institute for Drug Research, the School of Pharmacy, enables controlled drug release and increased bioavailability of orally administered lipophilic drugs.

Researchers from the Hebrew University, Tel Aviv University and Technion will conduct 20 research projects related to electronic auctions and markets

Pre-clinical trial shows excellent healing and complete bone repair 8 weeks post–osteotomy